Emerging cell and gene therapies, complex logistics eco-systems, and the need for greater industry collaboration

In this episode, we speak to Andreas Olpeter, Vice President of Sales & Business Development Healthcare at Arvato Supply Chain Solutions, and Andrea Zobel, Senior Director of Personalized Supply Chain at World Courier.

We discuss the emerging wave of new C&GT therapies and whether they are a niche, only available to small numbers of people, or if there is greater potential for wider patient access in the future. What are the complex ecosystems required for logistics success, and how will greater industry collaboration get more of these life-saving therapies to patients?

Hosted on Acast. See acast.com/privacy for more information.